Drug producer Kyowa Kirin helped the life sciences venture firm, a spinoff from Elan Corporation, close an oversubscribed $146m third fund.

The MIT cell therapy spinout priced its shares at the bottom of their range to raise $70.6m, following some $166m in venture funding.

Peking University-incubated Genskey provides high-sensitivity pathogen testing services in more than 20 Chinese provinces and municipalities.

The 3D-printed product supplier raised an eight-digit dollar amount in a round led by China Life Private Equity Investment Company.

Q&A with John Banta, president and managing director, Blue Venture Fund

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Cambridge Innovation Capital has backed a round sized at up to $50m for disease testing kit producer Sense Biodetection, which has now raised more than $64m altogether.

The AIG, Illumina, Alphabet and Orient Life-backed cell therapy developer priced its shares at the bottom of the range to raise $70.6m.

Legend Capital returned to reinvest in a $34.4m round for pathogen testing services provider Genskey, lifting its total funding above $55m.

The 3D-printed product supplier raised an eight-digit dollar amount in a round featuring Chinese Academy of Sciences.